CurrentCardio
Get Weekly

CurrentCardio coverage · page 6 of 9

JAMA Cardiology

Briefs 201–240 of 358 CurrentCardio has covered from this journal, newest publication first

Latest from JAMA Cardiology

All coverage, newest first

  1. JAMA Cardiol

    Cerebral Embolic Protection by Geographic Region: A Post Hoc Analysis of the PROTECTED TAVR Randomized Clinical Trial

    Secondary analysisValvular & structural

  2. JAMA Cardiol

    Coronary Revascularization Guided With Fractional Flow Reserve or Instantaneous Wave-Free Ratio: A 5-Year Follow-Up of the DEFINE FLAIR Randomized Clinical Trial

    Randomised controlled trialCoronary & ACS

  3. JAMA Cardiol

    Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

    Cohort studyHeart failure

  4. JAMA Cardiol

    Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial

    Secondary analysisHeart failure

  5. JAMA Cardiol

    Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

    Secondary analysisHeart failure

  6. JAMA Cardiol

    Kidney Outcomes in Transthyretin Amyloid Cardiomyopathy

    Cohort studyHeart failure

  7. JAMA Cardiol

    Partial Cardiac Denervation to Prevent Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: The pCAD-POAF Randomized Clinical Trial

    Randomised controlled trialCoronary & ACS

  8. JAMA Cardiol

    Amiodarone or Implantable Cardioverter-Defibrillator in Chagas Cardiomyopathy: The CHAGASICS Randomized Clinical Trial

    Randomised controlled trialArrhythmias & EP

  9. JAMA Cardiol

    Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in BAG3

    Cross-sectional studyHeart failure

  10. JAMA Cardiol

    Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: The REBALANCE-HF Randomized Clinical Trial

    Randomised controlled trialHeart failure

  11. JAMA Cardiol

    Global Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure

    Research articleHeart failure

  12. JAMA Cardiol

    Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction: A Post Hoc Analysis of the PACMAN-AMI Trial

    Secondary analysisCoronary & ACS

  13. JAMA Cardiol

    Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis

    Meta-analysisCoronary & ACS

  14. JAMA Cardiol

    Trends in Transcatheter Aortic Valve Replacement Outcomes: Insights From the STS/ACC TVT Registry

    Cohort studyValvular & structural

  15. JAMA Cardiol

    Additional Lesion Sets in Ablation of Outflow Tract Premature Ventricular Contractions: A Randomized Clinical Trial

    Randomised controlled trialArrhythmias & EP

  16. JAMA Cardiol

    Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors: The SAHELI Randomized Clinical Trial

    Randomised controlled trialPrevention & lipids

  17. JAMA Cardiol

    Genome-Wide Association Study of Accessory Atrioventricular Pathways

    Research articleArrhythmias & EP

  18. JAMA Cardiol

    Hospital Heart Failure Medical Therapy Score and Associated Clinical Outcomes and Costs

    Cohort studyHeart failure

  19. JAMA Cardiol

    Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort Study

    Cohort studyHeart failure

  20. JAMA Cardiol

    Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population

    Cohort studyHeart failure

  21. JAMA Cardiol

    Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis

    Cohort studyHeart failure

  22. JAMA Cardiol

    Tailoring Risk Prediction Models to Local Populations

    Cohort studyPrevention & lipids

  23. JAMA Cardiol

    Factors Underlying Reduced Hospitalizations for Myocardial Infarction During the COVID-19 Pandemic

    Cross-sectional studyCoronary & ACS

  24. JAMA Cardiol

    Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial

    Randomised controlled trialArrhythmias & EP

  25. JAMA Cardiol

    Prehospital Pulse-Dose Glucocorticoid in ST-Segment Elevation Myocardial Infarction: The PULSE-MI Randomized Clinical Trial

    Randomised controlled trialCoronary & ACS

  26. JAMA Cardiol

    Rates of Sudden Death After Myocardial Infarction—Insights From the VALIANT and PARADISE-MI Trials

    Secondary analysisCoronary & ACS

  27. JAMA Cardiol

    Routine Protamine Administration for Bleeding in Transcatheter Aortic Valve Implantation: The ACE-PROTAVI Randomized Clinical Trial

    Randomised controlled trialValvular & structural

  28. JAMA Cardiol

    Verinurad Plus Allopurinol for Heart Failure With Preserved Ejection Fraction: The AMETHYST Randomized Clinical Trial

    Randomised controlled trialHeart failure

  29. JAMA Cardiol

    Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial

    Secondary analysisPrevention & lipids

  30. JAMA Cardiol

    Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial

    Secondary analysisArrhythmias & EP

  31. JAMA Cardiol

    Efficacy and Safety of Lerodalcibep in Patients With or at High Risk of Cardiovascular Disease: A Randomized Clinical Trial

    Randomised controlled trialPrevention & lipids

  32. JAMA Cardiol

    Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis

    Meta-analysisValvular & structural

  33. JAMA Cardiol

    Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension: A Randomized Clinical Trial

    Secondary analysisHypertension

  34. JAMA Cardiol

    Climate Change and Cardiovascular Health: A Systematic Review

    Meta-analysisPrevention & lipids

  35. JAMA Cardiol

    Emergency Medical Service Agency Practices and Cardiac Arrest Survival

    Cohort studyAcute care & resuscitation

  36. JAMA Cardiol

    Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non–HDL-C Levels

    Cross-sectional studyPrevention & lipids

  37. JAMA Cardiol

    Neighborhood Social Vulnerability and Premature Cardiovascular Disease in Haiti

    Cohort studyHypertension

  38. JAMA Cardiol

    Plasma Proteomics of Exercise Blood Pressure and Incident Hypertension

    Diagnostic or prognostic studyHypertension

  39. JAMA Cardiol

    Postpartum Ambulatory Blood Pressure Patterns Following New-Onset Hypertensive Disorders of Pregnancy

    Cohort studyHypertension

  40. JAMA Cardiol

    Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk

    Case-control studyArrhythmias & EP

All 358 Briefs in ExploreShowing Briefs 201–240 of 358, newest first